NAMPT and melanoma: In fact, in vitro studies revealed that melanoma treatment with NAMPT inhibitors (NAMPTi) reduces NAD and ATP, depolarizes the inner mitochondrial membrane with loss of mitochondrial membrane potential, triggers ROS release, halts cells in the G2/M phase and induces apoptosis.